Nipple-Sparing Mastectomy and Immediate Tissue Expander/Implant Breast Reconstruction

Abstract

In the authors' series of nipple- and areola-sparing mastectomies performed for risk reduction or breast cancer, there was a low incidence of occult disease (5.2 percent). Nipple- and areola-sparing mastectomy may be feasible in selected patients and should be the subject of additional investigation.